Your browser is no longer supported. Please, upgrade your browser.
Settings
NVO Novo Nordisk A/S daily Stock Chart
NVO [NYSE]
Novo Nordisk A/S
Index- P/E21.73 EPS (ttm)2.16 Insider Own26.40% Shs Outstand2.02B Perf Week-0.40%
Market Cap94.45B Forward P/E19.33 EPS next Y2.42 Insider Trans0.00% Shs Float1.36B Perf Month-16.05%
Income5.50B PEG2.05 EPS next Q0.58 Inst Own10.00% Short Float0.16% Perf Quarter-15.62%
Sales16.83B P/S5.61 EPS this Y34.30% Inst Trans-1.57% Short Ratio1.06 Perf Half Y-7.40%
Book/sh2.56 P/B18.30 EPS next Y6.78% ROA41.50% Target Price57.00 Perf Year-13.07%
Cash/sh1.15 P/C40.67 EPS next 5Y10.60% ROE84.90% 52W Range44.94 - 57.43 Perf YTD-17.12%
Dividend1.41 P/FCF30.06 EPS past 5Y22.40% ROI85.00% 52W High-18.42% Beta0.71
Dividend %3.01% Quick Ratio0.90 Sales past 5Y12.20% Gross Margin84.80% 52W Low4.25% ATR0.93
Employees42265 Current Ratio1.30 Sales Q/Q1.50% Oper. Margin43.40% RSI (14)32.52 Volatility1.16% 1.33%
OptionableYes Debt/Eq0.01 EPS Q/Q21.50% Profit Margin32.70% Rel Volume0.75 Prev Close46.88
ShortableYes LT Debt/Eq0.00 EarningsAug 05 BMO Payout45.20% Avg Volume2.09M Price46.85
Recom3.00 SMA20-5.70% SMA50-9.74% SMA200-12.04% Volume1,561,100 Change-0.06%
Aug-08-16Downgrade BofA/Merrill Buy → Neutral
Aug-28-15Initiated Leerink Partners Mkt Perform $56
Jun-09-15Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-15-15Initiated Societe Generale Sell
May-28-13Upgrade Deutsche Bank Sell → Hold
Mar-31-10Initiated Deutsche Bank Hold
Mar-30-10Downgrade Mehta Partners Outperform → Market Perform
Feb-24-10Upgrade Jefferies & Co Hold → Buy
Jan-15-10Downgrade Jefferies & Co Buy → Hold
Sep-11-09Initiated Jefferies & Co Buy
Aug-07-09Downgrade UBS Buy → Neutral
Aug-07-09Downgrade JP Morgan Overweight → Neutral
May-12-09Initiated Piper Jaffray Buy
Apr-24-09Upgrade Citigroup Hold → Buy
Mar-26-09Upgrade UBS Neutral → Buy
Jan-14-09Downgrade Citigroup Hold → Sell
Oct-06-08Upgrade Deutsche Securities Hold → Buy
Aug-29-08Downgrade Bernstein Mkt Perform → Underperform
Aug-21-08Initiated UBS Neutral
Jun-09-08Upgrade HSBC Securities Underweight → Neutral
Aug-24-16 09:04AM  Why Did Novo Lower 2016 Sales Guidance?
Aug-23-16 07:04PM  Performance of AstraZenecas Growth Platforms in 2Q16
11:04AM  Whats Challenging Novos Leadership in the US Diabetes Space?
09:04AM  What Are the Prospects for Novos Biopharmaceuticals Segment?
Aug-22-16 01:14PM  Why Did Novos Valuation Multiple Fall Recently?
01:14PM  How Did Novos Diabetes and Obesity Care Segment Perform in 1H16?
11:54AM  FDAs Sanofi SA (ADR) (SNY) Delay Highlights Some Red Flags With IGlarLixi at Insider Monkey
11:48AM  ETFs with exposure to Novo Nordisk A/S : August 22, 2016
09:05AM  Can Allergan Generics Boost Teva Pharmaceuticals 2016 Revenues?
Aug-17-16 05:05PM  Inside Sanofis Valuation Changes
Aug-16-16 02:30PM  Novo Nordisk A/S Focuses on New Drugs at Motley Fool
Aug-15-16 07:30AM  Emisphere Reports Second Quarter 2016 Financial Results GlobeNewswire
Aug-14-16 07:18AM  3 Beaten-Up Big Pharma Stocks: Are They Bargains? at Motley Fool
Aug-12-16 01:17PM  Top 3 Research Reports for August 12, 2016
Aug-11-16 01:00PM  ETFs with exposure to Novo Nordisk A/S : August 11, 2016
Aug-10-16 10:18AM  Novo Nordisk A/S :NVO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016
09:42AM  Post Earnings Coverage as Novo Nordisk Tops Profit Expectations with 23 Percent Growth
09:15AM  Post Earnings Coverage as Novo Nordisk Tops Profit Expectations with 23 Percent Growth Accesswire
09:07AM  An Update on Analyst Recommendations for Novo
Aug-09-16 03:40PM  How Did Novo Nordisk Perform across Geographies in 1H16?
03:40PM  A Look at Novos 2Q16 Revenue and Earnings
12:12PM  The Cryptic World of Oral Insulin, Novo Nordisk A/S (ADR) (NVO) vs Oramed Pharmaceuticals, Inc. (ORMP) at Insider Monkey
Aug-08-16 04:38PM  Stocks End Mildly Lower; MaxLinear Plunges After Hours; Inphi Rises -5.49%
07:53AM  Novo Nordisk (NVO) Beats Q2 Earnings, Revenues Up Y/Y
07:39AM  Novo Nordisk A/S downgraded by BofA/Merrill
Aug-05-16 04:51PM  Novo Nordisk Plunges On Guidance Cut As Diabetes Sales Struggle -9.66%
09:14AM  European shares lifted by solid earnings but RBS slumps
05:20AM  Novo's insulin pill shows promise in mid-stage trial
05:02AM  Novo Nordisk beats 2Q profit forecasts
04:34AM  Novo Nordisk Shares Fall as It Trims Full-Year Guidance
04:16AM  Novo Nordisk Trims Full-Year Outlook
02:46AM  Novo Nordisk trims 2016 profit growth target
01:41AM  Novo Trims Full-Year Outlook Amid U.S. Price Pressure
01:41AM  Novo Nordisk Plummets Amid Pricing Challenges in U.S. Market at Bloomberg
Aug-04-16 11:40AM  Sam Isaly Adds to Stake in Novo Nordisk
Aug-02-16 04:09AM  Novos Victoza Diabetes Medicine Rebuffed by Express Scripts at Bloomberg
Aug-01-16 04:47PM  How Much Growth Will Novo See in 2Q16?
04:47PM  What Do Analysts Recommend for Novo?
Jul-28-16 07:15PM  Stocks With High Yield: Oracle, Cal-Maine, Infosys
Jul-26-16 10:55AM  European shares propped up by healthcare and consumer stocks
Jul-25-16 11:04AM  How Do the Majority of Analysts Rate Novartis after 2Q16?
Jul-22-16 04:11PM  Eli Lilly, J&J, Novo Battle Diabetes -- And Each Other
Jul-12-16 05:06PM  The CHMP Just Recommended the Extension of These Drugs Therapeutic Indications
03:26PM  My Favorite Health Care Stocks
Jul-08-16 12:01PM  *** DATA NOT AVAILABLE *** at noodls
Jul-06-16 11:40AM  Trump Or Hillary? Either Way, There's A Way To Profit at Forbes
Jun-30-16 07:06PM  Why Are Novo Nordisks Two Segments Growing?
04:06PM  What Are Analysts Thinking about Novo Nordisk?
09:20AM  Is $2.8 Billion Just The Beginning For This Novo Nordisk Diabetes Drug? at Motley Fool
Jun-29-16 09:07AM  Why Market Share for Novo Nordisks Tresiba Is Set to Grow
Jun-28-16 09:09AM  Could Novo Nordisks 2016 Earnings Impress Wall Street?
Jun-27-16 12:23PM  Evaluating Novo Nordisks Efficiency Based on EV-to-EBITDA
12:23PM  Novo Nordisks Premium Valuation Based on Price-to-Earnings
11:52AM  As Old Bestsellers Plateau, a Look at 4 Next Generation Diabetes Drugs at Insider Monkey
08:58AM  Research Report Initiated on Select Drug Manufacturers Equities
Jun-24-16 08:28AM  These 5 Stocks Could Be Toxic to Your Portfolio This Summer
Jun-22-16 03:37PM  How Big Is the Diabetes Treatment Market? at Motley Fool
12:20PM  The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All at Insider Monkey
Jun-20-16 08:38AM  What Is It About Novo Nordisk's Diabetes Drug That Makes It a Top Seller? at Motley Fool
07:59AM  5 Companies We'd Buy and Hold for the Next 20 Years at Motley Fool
Jun-18-16 09:03AM  Diabetes Deep-Dive: What Investors Need to Know About This Devastating Disease at Motley Fool
Jun-16-16 06:33PM  Why This Pharma Giant Lost $8 Billion in Market Cap This Week at Fortune
Jun-15-16 03:17PM  Novo Nordisk (NVO) Reports Positive Trial Results on Victoza
Jun-14-16 04:09PM  Novo Nordisk Drug Cuts Diabetic Deaths, But Not Enough For Wall Street
02:44PM  Can a Bunch of Doctors Keep an $8 Billion Secret? Not on Twitter at Bloomberg
02:43AM  Novo diabetes drug cuts heart risks by 13 pct in trial Reuters
Jun-13-16 08:52PM  Study Finds Victoza® Significantly Reduced the Risk of Heart Attack and Stroke in People with Type 2 Diabetes PR Newswire
05:17PM  This Diabetes Drug Saves Lives. You Can Thank The FDA at Forbes
05:15PM  Novo diabetes drug cuts heart risks by 13 pct in key trial Reuters
05:15PM  Novo Slumps as Study on Victozas Heart Impact Disappoints at Bloomberg
12:40PM  Faster-acting insulin aspart showed a statistically significant reduction in HbA(1c) in type 1 diabetes and a comparable HbA(1c) reduction in type 2 diabetes versus NovoRapid® (insulin aspart) PR Newswire
12:40PM  Faster-acting insulin aspart showed a statistically significant reduction in HbA(1c) in type 1 diabetes and a comparable HbA(1c) reduction in type 2 diabetes versus NovoRapid® (insulin aspart) CNW Group
Jun-12-16 11:15AM  IBM and American Diabetes Association Want to Transform the Future of Diabetes at Fortune
Jun-09-16 06:46PM  Wall Street Obesity Fund Could Make Your Wallet Fatter at Fortune
11:10AM  Introducing the Obesity ETF: Fighting Obesity, Dominated by Novo Nordisk and Fresenius at 24/7 Wall St.
Jun-03-16 07:17AM  Sell Alert: These 5 Stocks Look Toxic Right Now
Jun-02-16 06:47PM  Growing Yield and Profitability: Ross Stores, Novo Nordisk
Jun-01-16 09:56AM  Novo Nordisk (NVO) Reports Positive Data on Diabetes Drug
May-25-16 04:32PM  U.S. panel backs approval of Sanofi combination diabetes drug Reuters
03:50PM  Novo Nordisk IDegLira Recommended by FDA Advisory Committee
03:19AM  European shares hit new 4-week high, Novo Nordisk leads
May-24-16 04:27PM  U.S. FDA panel recommends approval of Novo Nordisk diabetes drug Reuters
May-23-16 07:44PM  Sanofi Is Shuffling Its Exec Roster Amid Continued Struggles at Fortune
01:05PM  FDA staff question usefulness of Sanofi diabetes drugs Reuters
09:18AM  FDA Staff Questions Usefulness of Sanofis Diabetes Drug Combo at Bloomberg
May-20-16 10:07AM  FDA staff question utility, trials of Novo Nordisk diabetes drug Reuters
08:50AM  FDA staff question utility of Novo Nordisk combo diabetes drug Reuters
May-18-16 10:35AM  Renaissance Technologies Bullish on PepsiCo (PEP) and Gold Heading Into Q2 at Insider Monkey
May-16-16 08:00AM  Emisphere Reports First Quarter 2016 Financial Results GlobeNewswire
May-13-16 06:02AM  We're Focused on What We're Good At, Says Nordisk CEO
06:02AM  We're Focused on What We're Good At, Says Nordisk CEO at Bloomberg
May-11-16 07:51PM  ETFs with exposure to Novo Nordisk A/S : May 11, 2016
May-10-16 10:14AM  Novo Nordisk A/S :NVO-US: Earnings Analysis: Q1, 2016 By the Numbers
May-09-16 05:06PM  Will Novos Modern Insulin Portfolio Fall Soon?
May-06-16 12:06PM  Novos Geographical Sales Split in 1Q16 Market Realist
May-05-16 07:11PM  Novo Nordisk A/S Injecting Future Sales at Motley Fool
May-03-16 03:30PM  Saxenda® demonstrated similar efficacy and safety profile across obesity severity stages CNW Group
May-02-16 08:00PM  Vanguard Launches 2 Dividend-Oriented International ETFs (VIGI, VYMI) at Investopedia
03:38PM  Novo Impressed Wall Street with Its 1Q16 Earnings Market Realist
03:38PM  How Has Novos Share Price Performed since Its Last Earnings? Market Realist
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity Care, and Biopharmaceuticals. The Diabetes and Obesity Care segment provides insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through distributors and independent agents in North America, Europe, Japan and South Korea, China, Hong Kong, Taiwan, and other countries. Novo Nordisk A/S has a collaboration agreement with the Langer Laboratory. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.